Michael Austwick - 01 Feb 2024 Form 3 Insider Report for Verona Pharma plc (VRNA)

Reporting relationship
Director
Issuer ticker
VRNA
Reported as of
01 Feb 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
02 Feb 2024, 06:05:12 UTC
Next SEC filing
29 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Claire Poll, Attorney-in-Fact for Michael Austwick

Key filing fact

Michael Austwick filed Form 3 for Verona Pharma plc (VRNA) on 02 Feb 2024.

Key facts

  • This page summarizes Michael Austwick's Form 3 filing for Verona Pharma plc (VRNA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Feb 2024, 06:05.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

SEC remarks

Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .